## First-Line Pharmacotherapy for OCD **Key Point:** SSRIs are the most commonly prescribed and evidence-based first-line pharmacological agents for OCD, with superior tolerability compared to older agents. ### Pharmacological Hierarchy in OCD Treatment | Agent Class | Role | Evidence | Tolerability | Typical Dose Range | |---|---|---|---|---| | **SSRIs** | **First-line** | **Strong (RCTs)** | **Excellent** | **40–80 mg/day (fluoxetine); 50–200 mg/day (sertraline)** | | Clomipramine | Second-line (or first if SSRI fails) | Strong | Moderate (anticholinergic, cardiac) | 150–250 mg/day | | Benzodiazepines | Adjunctive only (short-term anxiety) | Weak for OCD | Poor (dependence, abuse risk) | Variable | | Antipsychotics | Augmentation (if SSRI inadequate) | Moderate | Variable | Low-dose (risperidone 2–6 mg/day) | **High-Yield:** SSRIs require **higher doses and longer treatment duration** (8–12 weeks) in OCD compared to depression. Fluoxetine, sertraline, paroxetine, and citalopram are all FDA-approved for OCD. ### Why SSRIs Are First-Line 1. **Efficacy:** 40–60% response rate in OCD (vs. 30% placebo) 2. **Safety profile:** Minimal anticholinergic effects, no cardiac conduction delays 3. **Tolerability:** Fewer drug interactions, lower discontinuation rates 4. **Accessibility:** Widely available, lower cost 5. **Guideline support:** NICE, APA, and Indian psychiatric guidelines recommend SSRIs as first-line **Clinical Pearl:** Clomipramine, a tricyclic with potent serotonergic activity, was the first medication proven effective in OCD (1980s) but is now reserved for SSRI-refractory cases due to anticholinergic and cardiac side effects. **Mnemonic:** **SSRI-OCD** — SSRIs are the Serotonin-Selective standard for Routine Initial treatment of Compulsive Disorder. ### Management Algorithm ```mermaid flowchart TD A[OCD Diagnosis Confirmed]:::outcome --> B[SSRI First-Line]:::action B --> C[8-12 weeks at therapeutic dose]:::action C --> D{Response?}:::decision D -->|Yes| E[Continue + CBT/ERP]:::action D -->|No| F[Increase SSRI or switch SSRI]:::action F --> G{Response?}:::decision G -->|Yes| H[Maintenance]:::action G -->|No| I[Add augmentation: antipsychotic or clomipramine]:::action I --> J[Reassess at 4-6 weeks]:::decision ``` **Warning:** Benzodiazepines should NOT be used as monotherapy for OCD — they provide only short-term anxiety relief and carry high dependence risk. Antipsychotics are reserved for augmentation in SSRI-resistant cases.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.